Digestive & Intestinal Remedies (Pharmacies) - Indonesia

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$314.20m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.05%, resulting in a market volume of US$421.30m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$1.12 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Indonesia has been experiencing significant growth in recent years.

Customer preferences: Customers in Indonesia have shown a growing preference for digestive and intestinal remedies available in pharmacies. This can be attributed to several factors. Firstly, the increasing awareness and importance of digestive health among the population has led to a greater demand for products that can alleviate digestive issues. Secondly, the convenience of purchasing these remedies from pharmacies, which are easily accessible in both urban and rural areas, has contributed to the popularity of this distribution channel. Lastly, the trust and confidence that customers have in the quality and effectiveness of products available in pharmacies have also played a role in driving the demand for digestive and intestinal remedies.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Indonesia is the growing popularity of natural and herbal remedies. Customers are increasingly seeking products that are made from natural ingredients and are perceived to have fewer side effects. This trend is in line with the global shift towards more natural and holistic approaches to healthcare. As a result, pharmaceutical companies and manufacturers are developing and marketing a wide range of natural and herbal remedies to cater to this demand. Another trend in the market is the increasing availability and accessibility of over-the-counter (OTC) products. In Indonesia, regulations governing the sale of OTC medications have become more relaxed in recent years. This has allowed pharmacies to stock a wider range of digestive and intestinal remedies that can be purchased without a prescription. The ease of access to these products has contributed to their growing popularity among customers.

Local special circumstances: Indonesia is the fourth most populous country in the world, with a large and growing middle class. This demographic shift has led to increased spending power and a greater focus on personal health and well-being. As a result, the demand for digestive and intestinal remedies has seen a significant uptick. Furthermore, the country's diverse cuisine, which includes spicy and rich foods, can often lead to digestive issues. This local dietary characteristic has also contributed to the demand for remedies that can alleviate these symptoms.

Underlying macroeconomic factors: The overall growth of the Indonesian economy has had a positive impact on the Digestive & Intestinal Remedies market. As the economy continues to expand, more people have access to healthcare services and can afford to purchase these remedies. Additionally, the government's efforts to improve healthcare infrastructure and increase healthcare spending have also contributed to the growth of the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Indonesia is experiencing significant growth due to customer preferences for accessible and effective remedies, the popularity of natural and herbal products, the increasing availability of over-the-counter medications, local dietary habits, and the overall growth of the Indonesian economy. As these trends continue, the market is expected to further expand in the coming years.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.